LookCloser.aipublic supplement evidence
Exact product checked · GTIN 00852933008994OLLY · checked Jul 25, 2026🇺🇸 USPTO wordmark owner · OLLY PBC · DELAWARE, USA
Quick read · OLLY

Olly Lovin' Libido

Checked against public sources on July 25, 2026 · LookCloser does not sell or recommend supplements.

40capsules · 20 servings

Does the marketing hold up?

Category context: sexual-enhancement products carry documented FDA risk This is category history, not proof about this product, but it changes how much unsupported claims deserve to be trusted.

Is the dose real?Panel read — 3 ingredients listed
What a serving costs$0.84per serving, at the checked price
Is it tested?No testing claim made
Who’s behind it?🇺🇸OLLY PBCcorporation · DELAWARE, USA
Is it the real thing?Barcode matches outside records
Trouble on record?No recalls found

“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.

1◖ partly confirmed1△ support not foundno contradictions · no recalls
Marketing claims, checked

The checks, one by one

1 promise needs a closer look.

Partly confirmed1

“OLLY Lovin Libido Capsules, Boost Desire With Ashwagandha, Maca & Damiana,”

Published research exists for ingredients in this formula — see Related research below. Whether this product’s doses match those studies could not be confirmed.

Evidence →

Ingredient research can support context, but it is not a trial of this exact product.

Claimed without support found1

“and support sexual satisfaction for women* Clinically studied Ashwagandha helps support arousal and”

We found no named, citable study of this product or formula. The claim may rest on ingredient research rather than a trial of this product.

Evidence →
Quick read · 4 useful findings

What is worth knowing.

Headlines first. Open evidence only when you want the source trail.

Needs explanationAny trouble in public records?

Category context: sexual-enhancement products carry documented FDA risk

This is category history, not proof about this product, but it changes how much unsupported claims deserve to be trusted.

Evidence and sources

FDA's health-fraud program documents sexual-enhancement products as the most common supplement category found to contain undeclared prescription-drug ingredients. This is a category-level documented fact from FDA's public database — not a test result for this specific product. So…

Locked evidence record →Open the full source-linked finding
Checks outIs the label honest?

Every ingredient shows its amount · 3 ingredients listed.

Every ingredient shows its real amount — nothing is hidden in a proprietary blend.

Evidence and sources

The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.

Locked evidence record →Open the full source-linked finding
Checks outWho is behind it?

The barcode identity checks out · 852933008994.

The barcode matches, so we are checking the right product rather than a look-alike.

Evidence and sources

The brand's store lists this exact barcode as “Lovin' Libido” (variant: Default Title) — identity confirmed across retailer listings.

Locked evidence record →Open the full source-linked finding
What remains open 1
  • No matched to this exact product public label filing is saved in this record.

These are evidence gaps, not strikes against the product.

Who owns the brand wordmark?
🇺🇸
OLLY PBCCorporation · exact supplement-class mark for OLLY
Registration4783519
Registered2015-07-28
AssignmentsNo transfers recorded

Filed address
86 Graham Street, Suite 200, San Francisco, California 94129, UNITED STATES

USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗

Research behind the findings

Dose and research context

The label amount is shown beside the ranges used in the linked ingredient studies.

Background reading

What the research says about these amounts

Not a score. Studies disagree with each other and change over time, so this sits beside the evidence rather than counting toward it — it is here so you can read the sources yourself.

The panel lists 600 mg of ashwagandha per serving. Studies we found used 250 mg–600 mg a day, so this sits inside that range.

0studied 250 mg–600 mg

Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.

The panel lists 200 mg of maca root per serving. Studies we found used 1.5 g–3 g a day, so this sits below that range.

0studied 1.5 g–3 g

Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.

Where it sells

Price check for this exact product

Amazon

Exact UPC/GTIN match
$16.88

$0.84 per labeled serving

matching UPC/GTIN · checked Jul 25, 2026

View on Amazon ↗

Brand website

Exact UPC/GTIN match
$19.99

$1.00 per labeled serving

matching UPC/GTIN · checked Jul 25, 2026

View on Brand website ↗

iHerb

Exact UPC/GTIN match
$19.99

4.4/5 · 137 ratings

$1.00 per labeled serving

matching UPC/GTIN · checked Jul 25, 2026

View on iHerb ↗

Target

Not confirmed
No exact listing saved

Search results remain not linked to this exact product until this retailer publishes the matching UPC/GTIN.

Search Target ↗

Walmart

Not confirmed
No exact listing saved

Search results remain not linked to this exact product until this retailer publishes the matching UPC/GTIN.

Search Walmart ↗

Same UPC/GTIN observed across 3 sellers. Amazon was lowest at $16.88; iHerb was highest at $19.99 — a $3.11 range at check time.

The observed listing and exact brand page repeat 40 count. That confirms cross-page consistency of the published claim, not the product contents.

Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.

Want to inspect the evidence?

The full report shows every source, the exact unresolved question, and the documentation that would settle it.

Read / share full evidence →

Record built July 25, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.